Cargando…

Results of an early second PCR test performed on SARS-CoV-2 positive patients may support risk assessment for severe COVID-19

Identifying patients at increased risk for severe COVID-19 is of high priority during the pandemic as it could affect clinical management and shape public health guidelines. In this study we assessed whether a second PCR test conducted 2–7 days after a SARS-CoV-2 positive test could identify patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizrahi, Barak, Bivas-Benita, Maytal, Kalkstein, Nir, Akiva, Pinchas, Yanover, Chen, Yehezkelli, Yoav, Kessler, Yoav, Alon, Sharon Hermoni, Rubin, Eitan, Chodick, Gabriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516879/
https://www.ncbi.nlm.nih.gov/pubmed/34650138
http://dx.doi.org/10.1038/s41598-021-99671-5
_version_ 1784583889785716736
author Mizrahi, Barak
Bivas-Benita, Maytal
Kalkstein, Nir
Akiva, Pinchas
Yanover, Chen
Yehezkelli, Yoav
Kessler, Yoav
Alon, Sharon Hermoni
Rubin, Eitan
Chodick, Gabriel
author_facet Mizrahi, Barak
Bivas-Benita, Maytal
Kalkstein, Nir
Akiva, Pinchas
Yanover, Chen
Yehezkelli, Yoav
Kessler, Yoav
Alon, Sharon Hermoni
Rubin, Eitan
Chodick, Gabriel
author_sort Mizrahi, Barak
collection PubMed
description Identifying patients at increased risk for severe COVID-19 is of high priority during the pandemic as it could affect clinical management and shape public health guidelines. In this study we assessed whether a second PCR test conducted 2–7 days after a SARS-CoV-2 positive test could identify patients at risk for severe illness. Analysis of a nationwide electronic health records data of 1683 SARS-CoV-2 positive individuals indicated that a second negative PCR test result was associated with lower risk for severe illness compared to a positive result. This association was seen across different age groups and clinical settings. More importantly, it was not limited to recovering patients but also observed in patients who still had evidence of COVID-19 as determined by a subsequent positive PCR test. Our study suggests that an early second PCR test may be used as a supportive risk-assessment tool to improve disease management and patient care.
format Online
Article
Text
id pubmed-8516879
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-85168792021-10-15 Results of an early second PCR test performed on SARS-CoV-2 positive patients may support risk assessment for severe COVID-19 Mizrahi, Barak Bivas-Benita, Maytal Kalkstein, Nir Akiva, Pinchas Yanover, Chen Yehezkelli, Yoav Kessler, Yoav Alon, Sharon Hermoni Rubin, Eitan Chodick, Gabriel Sci Rep Article Identifying patients at increased risk for severe COVID-19 is of high priority during the pandemic as it could affect clinical management and shape public health guidelines. In this study we assessed whether a second PCR test conducted 2–7 days after a SARS-CoV-2 positive test could identify patients at risk for severe illness. Analysis of a nationwide electronic health records data of 1683 SARS-CoV-2 positive individuals indicated that a second negative PCR test result was associated with lower risk for severe illness compared to a positive result. This association was seen across different age groups and clinical settings. More importantly, it was not limited to recovering patients but also observed in patients who still had evidence of COVID-19 as determined by a subsequent positive PCR test. Our study suggests that an early second PCR test may be used as a supportive risk-assessment tool to improve disease management and patient care. Nature Publishing Group UK 2021-10-14 /pmc/articles/PMC8516879/ /pubmed/34650138 http://dx.doi.org/10.1038/s41598-021-99671-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Mizrahi, Barak
Bivas-Benita, Maytal
Kalkstein, Nir
Akiva, Pinchas
Yanover, Chen
Yehezkelli, Yoav
Kessler, Yoav
Alon, Sharon Hermoni
Rubin, Eitan
Chodick, Gabriel
Results of an early second PCR test performed on SARS-CoV-2 positive patients may support risk assessment for severe COVID-19
title Results of an early second PCR test performed on SARS-CoV-2 positive patients may support risk assessment for severe COVID-19
title_full Results of an early second PCR test performed on SARS-CoV-2 positive patients may support risk assessment for severe COVID-19
title_fullStr Results of an early second PCR test performed on SARS-CoV-2 positive patients may support risk assessment for severe COVID-19
title_full_unstemmed Results of an early second PCR test performed on SARS-CoV-2 positive patients may support risk assessment for severe COVID-19
title_short Results of an early second PCR test performed on SARS-CoV-2 positive patients may support risk assessment for severe COVID-19
title_sort results of an early second pcr test performed on sars-cov-2 positive patients may support risk assessment for severe covid-19
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516879/
https://www.ncbi.nlm.nih.gov/pubmed/34650138
http://dx.doi.org/10.1038/s41598-021-99671-5
work_keys_str_mv AT mizrahibarak resultsofanearlysecondpcrtestperformedonsarscov2positivepatientsmaysupportriskassessmentforseverecovid19
AT bivasbenitamaytal resultsofanearlysecondpcrtestperformedonsarscov2positivepatientsmaysupportriskassessmentforseverecovid19
AT kalksteinnir resultsofanearlysecondpcrtestperformedonsarscov2positivepatientsmaysupportriskassessmentforseverecovid19
AT akivapinchas resultsofanearlysecondpcrtestperformedonsarscov2positivepatientsmaysupportriskassessmentforseverecovid19
AT yanoverchen resultsofanearlysecondpcrtestperformedonsarscov2positivepatientsmaysupportriskassessmentforseverecovid19
AT yehezkelliyoav resultsofanearlysecondpcrtestperformedonsarscov2positivepatientsmaysupportriskassessmentforseverecovid19
AT kessleryoav resultsofanearlysecondpcrtestperformedonsarscov2positivepatientsmaysupportriskassessmentforseverecovid19
AT alonsharonhermoni resultsofanearlysecondpcrtestperformedonsarscov2positivepatientsmaysupportriskassessmentforseverecovid19
AT rubineitan resultsofanearlysecondpcrtestperformedonsarscov2positivepatientsmaysupportriskassessmentforseverecovid19
AT chodickgabriel resultsofanearlysecondpcrtestperformedonsarscov2positivepatientsmaysupportriskassessmentforseverecovid19